Collaboration Aims to Advance Nanomechanical Technology Platform for Optimizing Cancer Treatment

The University of Texas MD Anderson Cancer Center and ARTIDIS AG today announced a strategic alliance to investigate ARTIDIS technology as a novel treatment-optimization tool for patients with solid tumors in several distinct indications.

Related Keywords

Texas ,United States ,James Welsh ,Laura Thomsonoct ,Marija Plodinec ,Eugene Koay ,University Of Texas Md Anderson Cancer Center ,Cancer Center ,Radiation Oncology ,Gastrointestinal Radiation Oncology ,